首页> Journal of the National Cancer Center> TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study.

TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Aimin,Jiang

第一单位： Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.

作者： Aimin,Jiang ^[1] ; Ying,Liu ^[1] ; Ziwei,He ^[1] ; Wenqiang,Liu ^[1] ; Qiwei,Yang ^[2] ; Yu,Fang ^[1] ; Baohua,Zhu ^[1] ; Xiaofeng,Wu ^[1] ; Huamao,Ye ^[1] ; Bicheng,Ye ^[3] ; Shunxiang,Gao ^[4] ; Le,Qu ^[5] ; Wenhao,Xu ^[6] ; Peng,Luo ^[7] ; Linhui,Wang ^[1]

作者单位： Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China. ^[1] Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.;Department of Urology, the Third Affiliated Hospital of Naval Military Medical University (Eastern Hepatobiliary Surgery Hospital), Shanghai, China. ^[2] School of Clinical Medicine, Medical College of Yangzhou Polytechnic College, Yangzhou, China. ^[3] Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China. ^[4] Department of Urology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China. ^[5] Department of Urology, Fudan University Shanghai Cancer Center, State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institute of Biomedical Sciences, and Human Phenome Institute, Fudan University, Shanghai, China. ^[6] Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. ^[7]

关键词 Exosome Immunotherapy response Multiomics Non-invasive biopsy PLOD2 Renal cell carcinoma

DOI 10.1016/j.jncc.2024.07.002

PMID 39735439

发布时间 2025-01-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of the National Cancer Center

2024年4卷4期

382-394页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Journal of the National Cancer Center

2024年4卷4期

382-394页

检索历史清除

TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study.

Journal of the National Cancer Center

相似文献

同项目论文

Journal of the National Cancer Center

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study.

Journal of the National Cancer Center

相似文献

同项目论文

Journal of the National Cancer Center

相关期刊

检索历史清除